x
Breaking News
0

Mylan Inc (MYL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Mylan's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
40.52 +0.51    +1.27%
15/12 - Closed. Currency in USD ( Disclaimer )
After Hours
40.62
+0.10
+0.25%
22:59:41 GMT - Real-time Data
Type: Equity
Market: United States
ISIN: NL0011031208 
CUSIP: 001103120
  • Volume: 11,767,734
  • Bid/Ask: 40.52 / 43.12
  • Day's Range: 39.21 - 40.78
Start Trading
Mylan 40.52 +0.51 +1.27%

MYL Overview

 
Information about the Mylan Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close40.01
Day's Range39.21 - 40.78
Revenue11.94B
Open40.32
52 wk Range29.39 - 45.87
EPS1.62
Volume11,767,734
Market Cap21.73B
Dividend (Yield)0 (N/A)
Average Vol. (3m)5,973,698
P/E Ratio25.02
Beta1.36
1-Year Change7.31%
Shares Outstanding536,349,677
Next Earnings DateFeb 27, 2018
What is your sentiment on Mylan?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Buy Buy
Technical Indicators Sell Strong Buy Strong Buy Strong Buy Strong Buy
Summary Neutral Strong Buy Strong Buy Strong Buy Strong Buy

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Upside Gap Three Methods 30 Current
Engulfing Bearish 30 Current
Completed Patterns
Doji Star Bearish 1W 1 Dec 03, 2017
Engulfing Bearish 15 1 Dec 15, 2017 03:30PM
Bullish doji Star 1M 3 Sep 17

Mylan Inc News & Analysis

Mylan Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 40.52 40.52 43.12 11,767,734 +1.27% USD 15/12  
  Berlin 34.290 34.270 34.375 0 +3.19% EUR 15/12  
  Stuttgart 34.120 0.000 0.000 231 +0.59% EUR 15/12  
  Munich 34.530 0.000 0.000 13 +4.01% EUR 15/12  
  Tel Aviv 14,470 14,470 14,540 517,795 +3.80% ILS 14/12  
  Vienna 34.205 0.000 0.000 0 -0.87% EUR 15/12  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 173.97 174.17 172.46 +1.75 +1.02% 40.17M 15/12  
  Amazon.com 1,179.14 1,182.75 1,169.33 +4.88 +0.42% 4.78M 15/12  
  Tesla 343.45 343.90 335.76 +5.56 +1.65% 6.93M 15/12  
  Facebook 180.18 180.49 178.36 +1.79 +1.00% 28.46M 15/12  
  Alibaba 173.55 173.55 170.00 +1.80 +1.05% 41.36M 15/12  
  Walt Disney 111.27 112.00 110.60 +0.70 +0.63% 19.98M 15/12  
  Bitcoin Investment 2,699.00 2,750.00 2,470.00 +324.01 +13.64% 147.20K 15/12  
  CSX 52.93 53.59 51.63 -4.38 -7.64% 49.88M 15/12  
  NVIDIA 191.56 192.38 185.62 +5.09 +2.73% 16.75M 15/12  
  AMD 10.290 10.320 10.020 +0.160 +1.58% 45.46M 15/12  

Mylan Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

35000

Equity Type

ORD

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The Company's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Mylan Inc
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest MYL Comments

João Félix
João Félix Sep 29, 2017 7:42AM GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mylan shareholders vote against executive pay. .Directors face strong opposition. .These group of Directors don't have the profile and competency to manage Mylan at this moment in time. That is the main problem of this company.
Reply
0 0
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email